By | April 20 2010 6:17 AM

Through a joint-venture agreement with Artepharm Co. Ltd. (Artepharm China), Artepharm Global Corp. now owns the patent and worldwide marketing rights for Artequick, an anti-malaria drug developed by Artepharm China. Artequick is available in 11 countries with high rates of malaria infection.